• I_am_10_squirrels@beehaw.org
      link
      fedilink
      arrow-up
      5
      ·
      10 months ago

      I’m not a bacteriologist, but I do wonder why so much work is put towards finding new small molecule antibiotics instead of towards finding species-specific bacteriophages.

      • Gaywallet (they/it)@beehaw.orgM
        link
        fedilink
        arrow-up
        11
        ·
        10 months ago

        Both happen! It’s just work on phage therapy had to reinvent itself in the last decade or so and modern techniques are only just reaching maturity. We’re gonna see a lot more development in this space over the next decade.

      • Truck_kun@beehaw.org
        link
        fedilink
        English
        arrow-up
        5
        ·
        edit-2
        10 months ago

        I have not kept up on antibiotic resistance research, or phages in recent years.

        I do recall a number of years ago, I believe in the US, someone scooping up pond and garden soil samples looking for new phages.

        A quick search though, does show work on “phagemids”; the following article does mention that phages can cause harm to the human host by releasing harmful toxins in the bacteria when cell lysis is performed (potentially causing sepsis, or death), as well as bacteria do also develop resistance to phages over time.

        https://news.mit.edu/2015/engineered-particles-kill-harmful-bacteria-0625

        • appel@whiskers.bim.boats
          link
          fedilink
          arrow-up
          3
          ·
          10 months ago

          Don’t antibiotics also cause cell lysis? especially those like beta-lactams that interfere with cell wall maintenance

      • appel@whiskers.bim.boats
        link
        fedilink
        arrow-up
        4
        ·
        edit-2
        10 months ago

        I think bacteriophages should be investigated much more, unfortunately I don’t think big pharma is that interested in them, although they are also pretty uninterested in antibiotics too, because they generally don’t make much profit. So I think at least in this economic model in the west we are unlikely to have them widely available. I am admittedly quite out of date, all I remember is that there was more research and use of them in eastern europe/russia.

    • Truck_kun@beehaw.org
      link
      fedilink
      English
      arrow-up
      2
      ·
      10 months ago

      They will, but there is also the chance that in gaining that new resistance, they may give up a different resistance, or become less lethal.

      That’s the hopeful side of things; unfortunately, it is not uncommon for bacteria to develop resistance to a full combination of antibiotics over time, but I can be hopeful.

      • appel@whiskers.bim.boats
        link
        fedilink
        arrow-up
        3
        ·
        10 months ago

        resistance genes are often carried on transferable elements like transposons and plasmids, which often contain multi-gene cassettes encoding for many types of resistance. I would also like to be hopeful too, but every antibiotic we have developed has had resistance develop against it, also within multidrug resistant strains like MRSA and CRAB. I think we should be hopeful for phage therapy, as well as AB + phage combination therapy. I think relying purely on antibiotics is a bit of a dead end.